SPACELABS MEDICAL INC
3, 1997-09-02
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: NUVEEN INSURED CALIFORNIA PREMIUM INCOME MUNICIPAL FUND INC, DEF 14A, 1997-09-02
Next: EQUITRAC CORPORATION, 8-K, 1997-09-02



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
1. Name and Address of Reporting Person
   Messina, George P.
   Spacelabs Medical, Inc.
   15220 NE 40th Street
   Redmond, WA  98073
2. Date of Event Requiring Statement (Month/Day/Year)
   August 31, 1997
3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Issuer Name and Ticker or Trading Symbol
   Spacelabs Medical, Inc.
   SLMD
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   ( ) Director  ( ) 10% Owner  (X) Officer (give title below) ( ) Other
   (specify below)
   Senior Vice President
6. If Amendment, Date of Original (Month/Day/Year)
   
7. Individual or Joint/Group Filing (Check Applicable Line)
   (X) Form filed by One Reporting Person
   ( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Beneficially Owned                                                                           |
___________________________________________________________________________________________________________________________________|
1. Title of Security                       |2. Amount of          |3. Ownership    |4. Nature of Indirect                          |
                                           |   Securities         |   Form:        |   Beneficial Ownership                        |
                                           |   Beneficially       |   Direct(D) or |                                               |
                                           |   Owned              |   Indirect(I)  |                                               |
___________________________________________________________________________________________________________________________________|
<S>                                        <C>                    <C>              <C>
___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Beneficially Owned                                                                             |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative   |2.Date Exer-       |3.Title and Amount     |         |4. Conver-|5. Owner-    |6. Nature of Indirect      |
  Security              |  cisable and      |  of Underlying        |         |sion or   |ship         |   Beneficial Ownership    |
                        |  Expiration       |  Securities           |         |exercise  |Form of      |                           |
                        |  Date(Month/      |-----------------------|---------|price of  |Deriv-       |                           |
                        |  Day/Year)        |                       |Amount   |deri-     |ative        |                           |
                        | Date    | Expira- |                       |or       |vative    |Security:    |                           |
                        | Exer-   | tion    |         Title         |Number of|Security  |Direct(D) or |                           |
                        | cisable | Date    |                       |Shares   |          |Indirect(I)  |                           |
___________________________________________________________________________________________________________________________________|
<S>                     <C>       <C>       <C>                     <C>       <C>        <C>           <C>
 Stock Appreciation Righ|8/21/00  |9/20/00  |Common Stock           |64,094   |$22.38    |D            |                           |
t (1)                   |         |         |                       |         |          |             |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Employee stock option (r|(2)      |8/21/07  |Common Stock           |30,000   |$22.38    |D            |                           |
ight to buy) (1)        |         |         |                       |         |          |             |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
(1) Granted pursuant to Spacelabs Medical, Inc.'s 1992 Option, Stock 
Appreciation Right, Restricted Stock, Stock 
Grant and Performance Unit Plan which is exempt under Rule 
16b-3.
(2) Right to exercise 25% of the options granted, in equal annual installments 
beginning 8/21/98
SIGNATURE OF REPORTING PERSON
/s/George Messina by Eugene V.  DeFelice as attorney in fact



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission